Drug
Nevirapine clinical trials
Also written Viramune.
- studies test it
- 94
- open now
- 1
- in phase 3
- 29
- first study started
- 1998
Keep track of what changes. Save the Nevirapine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Studies by the year they started
70 studies that test it; most in 2006 (9)
| Year | Studies |
|---|---|
| 1998 | 3 |
| 1999 | 4 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 7 |
| 2005 | 8 |
| 2006 | 9 |
| 2007 | 9 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 22
- Phase 2
- 18
- Phase 3
- 29
- Phase 4
- 22
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 32 · Other 62
National Institute of Allergy and Infectious Diseases (NIAID) (26) · Boehringer Ingelheim (25) · Harvard School of Public Health (HSPH) (2) · Germans Trias i Pujol Hospital (2) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Bamrasnaradura Infectious Diseases Institute (2) · Bristol-Myers Squibb (2)
Often tested with
Tested in the same studies.
Lamivudine (23) · Zidovudine (20) · Lopinavir-ritonavir drug combination (13) · Stavudine (10) · Ritonavir (8) · Efavirenz (8) · Didanosine (7) · Atazanavir (6)
Studies
Open first, then newest update. How each study uses Nevirapine is read from its arms, and is right about nine times in ten.
Testing it · 94
- Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV RemissionRecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT02140255Written as Nevirapine (NVP)
- Early Infant HIV Treatment in BotswanaActive, not recruitingPhase 2/3Harvard School of Public Health (HSPH)NCT02369406Written as Nevirapine
- An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ SubjectsCompletedPhase 4Boehringer IngelheimNCT00144261Written as nevirapine
- A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic FunctionsCompletedPhase 4Boehringer IngelheimNCT00144248Written as nevirapine
- A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral TherapyCompletedPhase 2University of NebraskaNCT01789879Written as Nevirapine
- Using Nevirapine to Prevent Mother-to-Child HIV Transmission During BreastfeedingCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00074412Written as Nevirapine
- Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, BotswanaCompletedPhase 4Ann & Robert H Lurie Children's Hospital of ChicagoNCT03088410Written as Nevirapine
- Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited CountriesCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT01061151Written as Nevirapine (NVP): Antepartum Mothers
- Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00672412Written as Nevirapine
- Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00260078Written as Nevirapine
- Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00074581Written as Nevirapine
- Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their NewbornsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00006396Written as Nevirapine
- A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected MothersCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000808Written as Nevirapine
- A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and DidanosineCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000770Written as Nevirapine
- Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV DrugsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001083Written as Nevirapine
- Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the DiseaseCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001045Written as Nevirapine
- Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00312091Written as Nevirapine
- Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at BirthCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00102960Written as Nevirapine
- Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIVCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00270296Written as Nevirapine
- A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their InfantsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00001135Written as Nevirapine
See all 94 studies that test Nevirapine →
Given in every arm · 7 — Nevirapine is usual care beside what is tested
- Antiretroviral Regime for Viral Eradication in NewbornsCompletedPhase 4National Center for Women and Children's Health, China CDCNCT02712801Written as Nevirapine
- Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving BirthCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00109590Written as Nevirapine
- Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-InfectedCompletedPhase 1/2Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT01632891Written as Nevirapine
- Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected PatientsCompletedPhase 3Boehringer IngelheimNCT00819052Written as Nevirapine XR
- Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected PatientsCompletedPhase 4Boehringer IngelheimNCT02184299Written as Nevirapine
- Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African CommunitiesCompletedNot applicableCIPRA SANCT00255840Written as Nevirapine
- Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in UgandaCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00639938Written as Nevirapine
As the comparator · 6 — what is tested is compared with Nevirapine
- Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV PatientsTerminatedPhase 4Germans Trias i Pujol HospitalNCT00661349Written as Nevirapine
- Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected PatientsCompletedPhase 3Boehringer IngelheimNCT00819052Written as Nevirapine XR
- Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract in Healthy MalesCompletedPhase 1Boehringer IngelheimNCT02191189Written as Nevirapine suspension
- Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02184312Written as Nevirapine (VIRAMUNE®)
- Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited SettingCompletedPhase 4Centre Hospitalier Universitaire Saint PierreNCT01772940Written as nevirapine
- Triomune Bioequivalence With InnovatorsCompletedPhase 4Makerere UniversityNCT01025830Written as Zerit/Epivir/Viramune
Codes
What other systems call Nevirapine · ClinicalTrials.gg INT008731
- MeSH (NLM) D019829NevirapineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 99DK7FVK1HNEVIRAPINEConfirmed FDA, NLM, Wikidata
- RxNorm 53654Confirmed FDA, Wikidata
- Wikidata Q263713nevirapineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29277NevirapineOne source FDA
- DrugBank DB00238One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019829 | Nevirapine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 99DK7FVK1H | NEVIRAPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 53654 | — | Confirmed FDA, Wikidata |
| Wikidata | Q263713 | nevirapine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29277 | Nevirapine | One source FDA |
| DrugBank | DB00238 | — | One source Wikidata |
Also registered as nevirapine hemihydrate (UNII B7XF2TD73C · RxNorm 2462459).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.